Revisto, an Austin, TX-based AI-powered answer streamlining the medical, authorized, and regulatory (MLR) evaluation course of for pharmaceutical advertising supplies, raised $4M in Seed funding.
The spherical was led by LiveOak Ventures, with participation from Eli Lilly and Firm, Tau Ventures, and Arkin Digital Well being.
The corporate intends to make use of the funds to speed up its development because it continues to innovate and broaden its providers to fulfill the evolving wants of the life sciences trade.
Led by CEO Ferry Tamtoro, Revisto is an AI-powered platform enhancing the medical, authorized, and regulatory (MLR) evaluation course of for pharmaceutical advertising supplies by streamlining advertising operations, lowering prices, and eliminating compliance dangers.
The AI-powered evaluation answer leverages clients’ brand-specific knowledge and real-time FDA 21 CFR rules and tips to handle the ache factors within the MLR evaluation course of, which is hampered by a number of stakeholders, rules, and guide processes. The answer integrates into present evaluation workflows and CMS software program, like Veeva Vault PromoMats.
FinSMEs
18/11/2024
